Skip to main content

Table 3 Multivariate analysis of overall survival in stage I–III endometrial cancer patients

From: Cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study

Covariate

Overall survival

95% CI

Hazard ratio

P value

Pathological type

0.03

 Endometrioid

 

 Non-endometrioid

1.133–6.839

2.784

 

Myometrial invasion

1.139–6.400

2.700

0.02

Ovarian metastasis

1.603–50.477

8.994

0.01

Lymph node metastasis

3.708–25.245

9.675

< 0.01

Adjuvant therapy

0.18

 No

0.06

 Chemotherapy

0.857–329.210

16.792

0.03

 Radiotherapy

1.376–760.366

32.350

0.15

 Both

0.422–342.529

12.024

 
  1. OR odds ratio, CI confidence interval, LVSI lymphovascular space invasion
  2. A P value of < 0.05 was considered to be statistically significant
  3. Conferent: pathological type (endometrioid); myometrial invasion (< 50%); ovarian metastasis (−); lymph node metastasis (−); adjuvant therapy (no adjuvant therapy)